Diosmin

Spécifications

520-27-4Numéro CAS

208-289-7Numéro CE

5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-oneNom IUPAC

C28H32O15Formule chimique

608.5 g/molMasse molaire

diosmin; 520-27-4; Barosmin; Diosmine; Venosmine; Flebosten; Tovene; Ven-Detrex; Diovenor; Buchu Resin; Litosmil; flebosmil; Diosminum; Diosmetin 7-O-rutinoside; Diosven; Flebaven; Flebavena; Hemerven; Insuven; Varinon; Dioven; Diosmina; DTXSID4045892; 7QM776WJ5N; 3',5,7-trihydroxy-4'-methoxyflavone-7-rutinoside; 5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one; NSC-758417; CHEBI:4631; DTXCID2025892; 3',5,7-trihydroxy-4'-methoxyflavone 7-rhamnoglucoside; 5-hydroxy-2-(3-hydroxy-4-methoxy-phenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxy-chromen-4-one; 4H-1-Benzopyran-4-one, 7-((6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-; diosmiplex; Vasculera; Resin, Buchu; 5-hydroxy-2-(3-hydroxy-4-methoxy-phenyl)-7-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl)oxymethyl)tetrahydropyran-2-yl)oxy-chromen-4-one; 5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl)oxymethyl)oxan-2-yl)oxychromen-4-one; RefChem:35045; C05CA03; 208-289-7; Diosimin; Diosmil; Veno-V; Diosmetin-7-O-rutinoside; MFCD00009772; Rioven; Diosmin [INN]; 5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-((((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)-4H-chromen-4-one; Diosmin (INN); 4H-1-Benzopyran-4-one,7-[[6-O-(6-deoxy-a-L-mannopyranosyl)-b-D-glucopyranosyl]oxy]-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-; Diosmin, analytical standard; 5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-oxo-4H-1-benzopyran-7-yl 6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside; CAS-520-27-4; Diosmin [INN:BAN]; Diosmin [INN-Spanish]; Diosmine [INN-French]; Diosminum [INN-Latin]; SR-01000799147; 3',5,7-Trihydroxy-4'-methoxyflavone 7-rutinoside; UNII-7QM776WJ5N; CCRIS 7915; Barosmin;; Daflon;; Diosmin CRS; Luteolin 4'-methyl ether 7-rutinoside; Ven-Detrex;; NCGC00095022-01; 4H-1-Benzopyran-4-one, 7-((6-O-(6-deoxy-.alpha.-L-mannopyranosyl)-.beta.-D-glucopyranosyl)oxy)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-; 4H-1-Benzopyran-4-one, 7-[[6-O-(6-deoxy-.alpha.-L-mannopyranosyl)-.beta.-D-glucopyranosyl]oxy]-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-; Diosmin (Standard); EINECS 208-289-7; Daflon (TN); diosmetin-7-rutinose; Diosmin (8); SE 4601; Diosmin - 90%; Salinigricoflavonoloside;; Diosmetin 7-rutinoside;; DIOSMIN [DSC]; DIOSMIN [MI]; Diosmetin 7-b-rutinoside; DIOSMIN [MART.]; DIOSMIN [USP-RS]; DIOSMIN [WHO-DD]; 3',5,7-Trihydroxy-4'-methoxyflavone-7-(6-O-(-deoxy-alpha-L-mannopyraonsyl)-beta-D-glucopyranoside; MLS001304032; SCHEMBL120870; diosmetin-7-O-beta-D-rutinose; DIOSMIN [EP MONOGRAPH]; CHEMBL231884; orb1310207; orb3139707; SCHEMBL29368789; SCHEMBL29449210; SCHEMBL29558633; Diosmin for Sheperd's purse CRS; HY-N0178R; 3',5-Dihydroxy-4'-methoxy-4-oxo-4H-chromen-7-ylrutosid; BDBM153267; GLXC-13353; HMS2233P16; HMS3713L08; Diosmin for system suitability CRS; Tox21_111392; trihydroxymethoxyflavone-O-rutinoside; 3',5-Dihydroxy-4'-methoxy-4-oxo-4H-chromen-7-ylrutosid [IUPAC]; EBC-27379; LMPK12110814; s2292; AKOS015969767; Tox21_111392_1; CCG-208570; DB08995; NSC 758417; OD11673; SMP1_000183; NCGC00344564-01; NCGC00344564-07; 5-Hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-((6-O-alpha-L-rhamnopyranosyl-beta-D-glycopyranosyl)oxy)-4-chromenon; 5-HYDROXY-2-(3-HYDROXY-4-METHOXYPHENYL)-7-{[(2S,3R,4S,5S,6R)-3,4,5-TRIHYDROXY-6-({[(2R,3R,4R,5R,6S)-3,4,5-TRIHYDROXY-6-METHYLOXAN-2-YL]OXY}METHYL)OXAN-2-YL]OXY}-4H-CHROMEN-4-ONE; 7-[6-O-Deoxy-a-L-mannopyranosyl)-b-D-glucopyranosyl)oxy]-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one; AS-13224; BP-12422; SMR000718616; SY076010; NS00005135; C10039; D07858; EN300-18388399; F795402; 3',5,7-trihydroxy-4'-methoxy flavone-7-rutinoside; Q2607865; SR-01000799147-4; SR-01000799147-5; SR-01000799147-6; 3?,5,7-Trihyd roxy-4?-methoxyflavone 7-rutinoside; BRD-K94436377-001-10-2; BRD-K94436377-001-11-0; Diosmin, European Pharmacopoeia (EP) Reference Standard; 3',5,7-Trihydroxy-4'-methoxyflavone 7-rutinoside;; Diosmin; Barosmin; 3',5,7-Trihydroxy-4'-methoxyflavone 7-rutinoside; Diosmin, United States Pharmacopeia (USP) Reference Standard; Diosmin for system suitability, European Pharmacopoeia (EP) Reference Standard; 5-Hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-oxo-4H-chromen-7-yl 6-O-(6-deoxy-?-L-mannopyranosyl)-?-D-glucopyranoside; 5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-((((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)-4H-chrome; 5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-(O6-alpha-L-rhamnopyranosyl-beta-D-glucopyranosyloxy)chromen-4-one; 5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one; 7-((6-O-(6-DEOXY-GA-L-MANNOPYRANOSYL)-.BETA.-D-GLUCOPYRANOSYL)OXY)-5-HYDROXY-2-(3-HYDROXY-4-METHOXYPHENYL)-4H-1-BENZOPYRAN-4-ONE; 7-((6-O-(6-Deoxy-ga-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-oneSynonymes